Long-term anti-TNF therapy for ankylosing spondylitis in two patients with chronic hepatitis B

被引：0
|
作者：
Sakellariou, G. T. [1 ]
Vezyriclis, C. [1 ]
Sidiropoulos, P. [1 ]
Chatzigiannis, I. [1 ]
机构：
[1] St Pauls Hosp, Thessaloniki, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：541 / 541
页数：1
相关论文
共 50 条
  • [31] SECONDARY AMYLOIDOSIS IN ANKYLOSING SPONDYLITIS AND THE ROLE OF ANTI-TNF THERAPY
    Donmez, S.
    Pamuk, O. N.
    Pamuk, G. E.
    Aydogdu, E.
    Inman, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 613 - 613
  • [32] Anti-TNF Therapy Slows Radiographic Progression of Ankylosing Spondylitis
    Haroon, Nigil
    Inman, Robert D.
    Learch, Thomas J.
    Weisman, Michael H.
    Ward, Michael M.
    Reveille, John D.
    Gensler, Lianne S.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S339 - S340
  • [33] Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
    Vassilopoulos, D.
    Apostolopoulou, A.
    Hadziyannis, E.
    Papatheodoridis, G. V.
    Manolakopoulos, S.
    Koskinas, J.
    Manesis, E. K.
    Archimandritis, A. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) : 1352 - 1355
  • [34] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Pinar Borman
    Figen Ayhan
    Esma Ceceli
    Rheumatology International, 2010, 30 : 1689 - 1690
  • [35] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Borman, Pinar
    Ayhan, Figen
    Ceceli, Esma
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (12) : 1689 - 1690
  • [36] ANTI-TNF ALPHA DOSE REDUCTION IN ANKYLOSING SPONDYLITIS PATIENTS
    Ortolan, A.
    Chimenti, M. S.
    Lorenzin, M.
    Frallonardo, P.
    Sunzini, F.
    Conigliaro, P.
    Perricone, R.
    Punzi, L.
    Ramonda, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1128 - 1128
  • [37] ETHNIC DIFFERENCES IN THE RESPONSE TO ANTI-TNF IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Adshead, Rebecca
    Tahir, Hasan
    Bubbear, Judith
    Donnelly, Simon
    Chau, Iggy
    RHEUMATOLOGY, 2015, 54 : 133 - 134
  • [38] Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
    Coskun, Belkis Nihan
    Yagiz, Burcu
    Corabay, Seniha Gunduz
    Pehlivan, Yavuz
    Dalkilic, Ediz
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (02) : 68 - 74
  • [39] Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
    Baraliakos, Xenofon
    Haibel, Hildrun
    Listing, Joachim
    Sieper, Joachim
    Braun, Juergen
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) : 710 - 715
  • [40] THE RELATIONSHIP BETWEEN ANTI-TNF THERAPY USE AND METABOLIC SYNDROME IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Ferhatosmanoglu, A.
    Celik, S.
    Kanitez, N. Alpay
    Caf, N.
    Yilmaz-Oner, S.
    Bes, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 647 - 647
12345